- NURA Dispatch - Long COVID & ME/CFS
- Posts
- ME/CFS research insights, brain fog breakthrough and virtual meetups galore
ME/CFS research insights, brain fog breakthrough and virtual meetups galore
Good morning, happy Wednesday, and welcome again to NURA Dispatch. We’re the NURA Community newsletter dedicated to all things long COVID and ME/CFS.
❗ Can you think of a better name for this newsletter? Hit us up with your suggestions.
In this newsletter:
🧠 Brain fog and a leaky blood-brain barrier
🖥️ More NURA virtual events
🏥 That NIH ME/CFS study, and patient involvement in biomedical research
🎨 Creativity and chronic illness
📅 Long COVID and disability webinar
✈️ Missing travel?
🧠 Do you struggle with brain fog as part of your long COVID or ME/CFS?
We asked NURA members this. 93% said yes.
So what causes brain fog? New research by Trinity College Dublin scientists, published last week, found that a leaky blood-brain barrier could be the cause of brain fog in long COVID patients. Er, are our brains leaking?
The blood-brain barrier controls which substances or materials enter and exit the brain. “It’s all about regulating a balance of material in blood compared to brain,” said Professor Matthew Campbell, co-author of the research.
“If that is off balance then it can drive changes in neural function and if this happens in brain regions that allow for memory consolidation/storage then it can wreak havoc.”
In the research, it was discovered, among other things, that long COVID patients who reported having brain fog did indeed show signs of a leaky blood-brain barrier. Participants without this symptom, and participants who had recovered from COVID, did not.
It’s worth noting that the term “brain fog” likely doesn’t adequately convey most patients’ experience of this symptom, particularly to those who don’t have it.
“…I’ve had ADHD-style symptoms, loss of speech/vocabulary and stuttering, an inability to do maths and more symptoms too.”
“I feel like I'm experiencing life through a periscope. My brain is having to do all kinds of extra processing to interpret all the sensory input.”
“[It’s like] My thoughts become a musket after a week of trudging through rain. I can load, I can aim, I can even try to fire. But there is no spark. The powder's damp. It... just... doesn't work. And when it does, it's too late: the target has moved on.”
Matthew Campbell added that it was possible that people with a tighter blood-brain barrier might be better protected from brain fog, should they develop long COVID. This may explain why brain fog does not arise in all long COVID patients.
"For the first time, we have been able to show that leaky blood vessels in the human brain, in tandem with a hyperactive immune system, may be the key drivers of brain fog associated with long COVID. This is critically important, as understanding the underlying cause of these conditions will allow us to develop targeted therapies for patients in the future."
💡 Whilst the research focused solely long COVID, its findings may have relevance to other - and related - conditions like ME/CFS in which brain fog is also a symptom.
🏡 Community corner
Do you have any more advice for this NURA member looking to get help with POTS?
Join our next virtual meet tomorrow (Thursday 7th March) at 7PM (if you’re in the UK). If you’re elsewhere, it’ll hopefully be doable for you, too (unless you’re in Western Australia - sorry!). If there’s ever an issue with times, just let us know by replying to this email.
If you haven’t been back for a while, now’s the perfect time to catch up below.
NURA members have been sharing their experiences on the difficulties on pushing through while working with long COVID or ME/CFS, pronouncing “encephalomyelitis” and small daily habits that bring joy.
We know everyone wants different things from online communities - particularly ones for chronic illness - so we want to hear from you. Tell us what you’d value.
📰 The NIH ME/CFS study
ME/CFS study participant Brian Vastag (right) with study leader Avindra Nath (from Science)
🧪 The long-awaited ME/CFS research study by NIH, which started eight years ago, published its results last week. The study represents the deepest dive yet into the illness, a “megaworkup” of 17 people with post-infectious ME/CFS who had been sick for less than five years, and 21 healthy controls. Researchers found differences in the brains and immune systems of people with post-infectious ME/CFS. They also found distinct differences between men and women with the disease.
Sounds great, right?! Yes…and no. Not to be a buzzkill, but patients, scientists and advocates have raised serious concerns about the research, which cost more than $8m 💰💰💰. We’ve broken it down below.
😊👍 The good:
The study has brought much-needed visibility to ME/CFS by garnering the attention of mainstream media.
The paper stands out for its interdisciplinary collaboration; by bringing together experts from diverse fields, the study has revealed a more complete picture than previously fragmented pieces of the ME/CFS puzzle, and provided a more comprehensive understanding.
The research leaves no doubt: ME/CFS is a disease with clear biological hallmarks. The findings confirm that “it’s biological, not psychological,” said Dr. Avindra Nath, the chief of infections of the nervous system at the National Institute of Neurological Disorders and Stroke, who led the study.
“We’re kind of like at the point of trying to get understood, so this study is a big deal…For so long I’ve been gaslit, dismissed, invalidated, belittled, so the validation is huge for me.”
😔👎 The bad:
The study was small, and may not reflect the experience of many people with ME/CFS, particularly those whose illness onset was not post-infectious.
More moderately and severely affected patients were not included; the study participants had to be functional enough to undergo intense evaluation during days of visits to the NIH.
The study did not find some of the well-established medical signatures of ME/CFS that have been documented by other research.
Strange, misleading language was used, such as “effort preference”. This is a term used in psychology which means “willingness to exert”. It goes without saying that people with ME/CFS are cautious about overexertion (due to post-exertional malaise) and have lower effort preference than healthy controls, so the decision to include it and make it so central to the paper seems odd, given it is not measured in most neurological diseases.
The study doesn’t answer the single most important question: what is actually causing ME/CFS, and how can it be treated?
“Perhaps most importantly, the glaring absence of patient voices at all stages of this project reflects a huge missed opportunity and contributed to the lackluster outcomes of the study.”
Read ME Action’s analysis of the study here.
WORD OF THE WEEK
Hurkle-durkle
Verb
To lounge around in bed long after you should have gotten up
From 19th-century Scots (and later, TikTok)
🐦 Top Tweet
Long COVID researcher David Putrino, in response to the CDC’s updated guidance stating that people with respiratory illnesses do not have to self-isolate for 5 days, and can resume daily activities if they have been fever-free for at least 24 hours without the aid of medications, and if their symptoms are improving
💡 Why patient involvement in research actually matters
In light of the NIH research study outlined above, it’s worth revisiting this NY Times article on what it means to listen to patients in biomedical research, in the context of post-viral illness. Though, as science writer Julie Rehmeyer pointed out, it’s not about involving patients merely for the sake of kindness or inclusion; it’s about really capitalising on the wealth of expertise - genuine, substantive, scientifically-informed expertise - that patients have about their illnesses.
Patients are often meticulous record-keepers, and delve into their medical journeys with impressive precision, perseverance and creativity (see this wonderfully illustrated essay from a COVID long hauler here). Often left to navigate our illnesses alone, particularly with conditions like ME/CFS and long COVID with their myriad uncertainties, we engage in self-experimentation, sharing our findings and formulating our own hypotheses and approaches. But perhaps the most remarkable attribute of patients is their adeptness at networking; they will often find themselves connecting and speaking to fellow sufferers by the thousands. This is the kind of knowledge that researchers often just don’t - and perhaps can’t - have. It’s no surprise then, that better engagement with patients → better research.
🚨 See here for details on how to participate in Yale’s LISTEN study on long COVID.
❓ How have you found the experience of connecting with other people with your condition? How has your experience with chronic illness influenced your perspective on healthcare research? Tell us here anonymously, and we’ll share it next time.
Quoted
Reminding myself that every emotion and symptom changes with time, so I tell myself that even if a symptom is particularly bad one day, it will inevitably lighten up on another day. I know I'm lucky that I can think like that in terms of my experience with my symptoms, but it certainly helps.
👋 New intros
Say hi to new NURA members here.
🔦 Member Spotlight
✍️🕸️ This creative writing piece by community member Lydia cleverly compares chronic illness to a spider. Lydia shares her journey with her own spider, born from a viral infection, and the unique webs it spins.
Some spiders have more legs, whilst others have less. Mine has eight, with each leg spinning a web of change, impacting my ability to move, live independently, earn money and some days, even leave my bed. This spider created its home suddenly, following a viral infection that gifted it the venom it needed to paralyse me with a constant exhaustion.
📖 Want to share your story?
If you're creative in any way - whether you write, draw, take photos, keep journals, or pursue any other form of self-expression - we want to hear from you. Share your unique perspective about living with long COVID or ME/CFS. Reach out by replying to this email.
🎨✍️📸🎭🎼🖌️🎬🎻
🛠️ And finally, some helpful things…
From us:
Check out our events, including our fortnightly Zoom support sessions. These are relaxed spaces in which to chat, meet others, or just listen. | Contribute to our long COVID and ME/CFS Insight Bank. What have you found helpful, and what would you tell others? |
What brought you some joy this week? Share with the community, and cheer on others’ good moments in our Little Wins space.
From others:
🌍 Has your illness impacted your ability to travel and explore freely? Rick Steves’ Europe travel series, all on YouTube, may lift your spirits. The 25-minute videos are quirky, calming, exceedingly wholesome, and the word “quaint” is used just the right amount. | 📊 Are you in the US? Solve ME’s patient-centred platform and symptom tracker makes data accessible to researchers; it also connects US researchers with US patients looking to take part in clinical trials. It’s free to use, has pacing notifications and downloadable reports, and connects to your wearables. |
That’s it for now! Until next time.
❓ If you have any thoughts, comments or questions on anything in this newsletter, just reply directly to this email. We’d love to hear from you.
🔍 Is this newsletter accessible and easy for you to read? Let us know.
➡️ Please use the link below to share this newsletter with anyone you think might enjoy it 👇
✉️ Been forwarded this newsletter? Subscribe below 👇
Reply